UOB Kay Hian Private Limited
Wednesday, 28 May 2025
China Sunsine Chemical: Holding Steady Amid Pricing Pressure
China Sunsine Chemical (CSSC SP) demonstrates resilience amid pricing pressures, supported by China’s robust automotive market. Vehicle sales in 1Q25 and April 2025 increased by 11% and 10% year-over-year, respectively. While average selling prices (ASPs) have decreased due to lower feedstock costs, the company’s market leadership and capacity provide a competitive edge. Earnings forecasts for 2025-2027 have been adjusted down by 1-3% due to ASP weakness, though volume growth remains strong. The company maintains a BUY rating with a target price of S\$0.63, backed by a solid net cash position and a 5.2% yield. [[1]]
Sustained Automotive Growth Boosts Rubber Accelerator Demand
- According to the China Association of Automobile Manufacturers (CAAM), auto sales in 1Q25 reached 7.47 million units, an 11% increase year-over-year. [[1]]
- New energy vehicles (NEV) surged by 47% year-over-year, accounting for 41% of total new car sales. [[1]]
- The strong momentum in vehicle production and electrification continues to drive demand for downstream materials like rubber accelerators. [[1]]
- CAAM projects total vehicle sales of 32.9 million for 2025, a 4.7% year-over-year increase, supporting robust demand for rubber accelerators. [[1]]
Decline in Main Feedstock Aniline Prices
- The ASP of rubber accelerators has declined by around 18% year-over-year, in tandem with a 39% year-over-year fall in aniline prices, its key feedstock. [[2]]
- This decline is largely due to lower crude oil prices, as aniline is derived from benzene, a petroleum-based input. [[2]]
- Increased aniline supply from resumed production capacity has further weighed on prices. [[2]]
- While lower raw material costs may offer some cost relief to Sunsine, the decline in ASPs is expected to offset most of the margin gains. [[2]]
1Q25 Performance Review
- Sunsine reported earnings of Rmb108 million (+27% year-over-year), forming 25% of the forecast and in line with expectations. [[2]]
- Revenue came in at Rmb839 million, slightly missing expectations by 2%, due to a 2% decline in ASP to Rmb15,592/tonne. [[2]]
- Sales volume increased marginally to 53,093 tonnes (+1% year-over-year). [[2]]
- The lower ASP was attributed to both lower raw material costs and Sunsine’s continued flexible pricing strategy. [[2]]
- Gross margin improved 0.7ppt year-over-year to 24.1% in 1Q25, supported by lower input costs. [[2]]
Key Financials
The following table summarizes the key financials for China Sunsine Chemical:
Year to 31 Dec (Rmbm) |
2023 |
2024 |
2025F |
2026F |
2027F |
Net turnover |
3,490 |
3,516 |
3,500 |
3,592 |
3,702 |
EBITDA |
604 |
718 |
770 |
794 |
818 |
Operating profit |
453 |
585 |
602 |
615 |
630 |
Net profit (rep./act.) |
372 |
424 |
436 |
446 |
456 |
Net profit (adj.) |
372 |
424 |
436 |
446 |
456 |
EPS (Fen) |
38.8 |
44.5 |
45.7 |
46.8 |
47.9 |
PE (x) |
8.1 |
7.1 |
6.9 |
6.8 |
6.6 |
P/B (x) |
0.8 |
0.7 |
0.7 |
0.6 |
0.6 |
EV/EBITDA (x) |
1.0 |
0.9 |
0.8 |
0.8 |
0.8 |
Dividend yield (%) |
4.1 |
4.9 |
5.2 |
5.4 |
5.7 |
Net margin (%) |
10.7 |
12.1 |
12.5 |
12.4 |
12.3 |
Net debt/(cash) to equity (%) |
(43.0) |
(49.3) |
(53.3) |
(56.3) |
(59.1) |
Interest cover (x) |
n.a. |
n.a. |
n.a. |
n.a. |
n.a. |
ROE (%) |
9.8 |
10.4 |
10.0 |
9.6 |
9.2 |
Consensus net profit |
– |
– |
439 |
455 |
470 |
UOBKH/Consensus (x) |
– |
– |
0.99 |
0.98 |
0.97 |
Stock Impact
- Sunsine is the world’s largest producer of rubber accelerators, with an annual capacity of 117,000 tonnes. [[2]]
- This scale advantage enables greater pricing flexibility and cost efficiency, supporting its leading 35% share of the China market and 23% globally as of 2024. [[2]]
- The company operates on a “sales and production equilibrium” model, expanding volume to drive scale and competitiveness. [[2]]
Attractive Dividend Yield
- Sunsine provides an attractive yield of 5.2%, supported by its strong cash position of Rmb2,074m (+23% yoy) as of end-24. [[2]]
- This translates to Rmb2.18/share (S\$0.40/share) or around 70% of its market cap. [[2]]
- This provides ample room for Sunsine to potentially raise its dividend and continue to perform share buybacks. [[2]]
Earnings Revision/Risk
- Revenue forecasts for 2025-27 have been revised downward by 4-6% to reflect continued pressure on ASPs. [[2]]
- Volume growth remains intact, but pricing weakness from intense competition and lower raw material costs has weighed on top-line assumptions. [[2]]
- R&D expenses forecast was trimmed per management’s latest guidance, which partially offsets the earnings impact. [[2]]
- As a result, earnings estimates for 2025-27 are lowered by 1-3%. [[2]]
Valuation/Recommendation
- Maintain BUY with an unchanged target price of S\$0.63, pegged to a PE multiple of 7.5x 2025F earnings, or 1SD above the mean PE. [[2]]
- The stock trades at an attractive valuation of 1.3x ex-cash 2025F PE. [[2]]
Share Price Catalysts
- New manufacturing capacities commencing production. [[2]]
- Higher ASPs for rubber chemicals. [[2]]
- Higher-than-expected utilisation rates. [[2]]
Peer Comparison
The following table compares China Sunsine Chemical to its peers:
Company |
Ticker |
Trading Price @ 27-May-25 (lcy) |
Market Cap (US\$m) |
PE 2025 (x) |
PE 2026 (x) |
P/B 2025 (x) |
P/B 2026 (x) |
EV/EBITDA 2025 (x) |
EV/EBITDA 2026 (x) |
ROE 2025 (%) |
Yield 2025 (%) |
China Sunsine |
CSSC SP |
S\$ 0.565 |
419 |
6.9 |
6.6 |
0.7 |
0.6 |
1.1 |
1.0 |
9.9 |
5.2 |
Shandong Yanggu Huatai |
300121 CH |
CNY 15.43 |
963 |
15.7 |
12.0 |
1.9 |
1.7 |
n.a. |
n.a. |
12.0 |
n.a. |
Lanxess AG |
LXS GR |
EUR 26.18 |
2,566 |
47.6 |
20.0 |
0.5 |
0.5 |
7.8 |
6.8 |
(0.7) |
0.8 |
Eastman Chemical |
EMN US |
USD 80.54 |
9,299 |
10.9 |
9.8 |
1.5 |
1.4 |
8.1 |
7.5 |
14.0 |
4.1 |
Arkema SA |
AKE FP |
EUR 63.75 |
5,504 |
8.9 |
7.7 |
0.6 |
0.6 |
5.3 |
4.9 |
6.8 |
5.7 |
Average |
|
|
|
20.8 |
12.4 |
1.1 |
1.1 |
7.0 |
6.4 |
8.0 |
3.6 |
Profit & Loss
The following table presents the Profit & Loss statement:
Year to 31 Dec (Rmbm) |
2024 |
2025F |
2026F |
2027F |
Net turnover |
3,515.5 |
3,500.0 |
3,591.8 |
3,702.4 |
EBITDA |
718.0 |
770.0 |
793.8 |
818.2 |
Deprec. & amort. |
132.9 |
168.3 |
178.4 |
188.5 |
EBIT |
585.1 |
601.6 |
615.4 |
629.7 |
Associate contributions |
0.0 |
0.0 |
0.0 |
0.0 |
Net interest income/(expense) |
0.0 |
0.0 |
0.0 |
0.0 |
Pre-tax profit |
585.1 |
601.6 |
615.4 |
629.7 |
Tax |
(161.2) |
(165.8) |
(169.5) |
(173.5) |
Minorities |
0.0 |
0.0 |
0.0 |
0.0 |
Net profit |
423.9 |
435.9 |
445.8 |
456.2 |
Net profit (adj.) |
423.9 |
435.9 |
445.8 |
456.2 |
Balance Sheet
The following table presents the Balance Sheet:
Year to 31 Dec (Rmbm) |
2024 |
2025F |
2026F |
2027F |
Fixed assets |
835.0 |
811.4 |
777.9 |
734.5 |
Other LT assets |
270.0 |
195.0 |
190.7 |
186.3 |
Cash/ST investment |
2,073.9 |
2,397.2 |
2,696.0 |
3,000.9 |
Other current assets |
1,500.1 |
1,579.2 |
1,620.7 |
1,670.6 |
Total assets |
4,679.0 |
4,982.9 |
5,285.3 |
5,592.3 |
ST debt |
0.0 |
0.0 |
0.0 |
0.0 |
Other current liabilities |
470.3 |
486.6 |
498.8 |
512.9 |
LT debt |
0.0 |
0.0 |
0.0 |
0.0 |
Other LT liabilities |
0.0 |
0.0 |
0.0 |
0.0 |
Shareholders’ equity |
4,208.7 |
4,496.3 |
4,786.5 |
5,079.3 |
Minority interest |
0.0 |
0.0 |
0.0 |
0.0 |
Total liabilities & equity |
4,679.0 |
4,982.9 |
5,285.3 |
5,592.3 |
Cash Flow
The following table summarizes the Cash Flow:
Year to 31 Dec (Rmbm) |
2024 |
2025F |
2026F |
2027F |
Operating |
573.3 |
537.2 |
590.7 |
604.6 |
Pre-tax profit |
585.1 |
601.6 |
615.4 |
629.7 |
Tax |
(102.2) |
(161.4) |
(165.9) |
(169.7) |
Deprec. & amort. |
128.7 |
164.2 |
174.1 |
184.1 |
Working capital changes |
58.6 |
(67.2) |
(32.8) |
(39.5) |
Non-cash items |
(96.9) |
0.0 |
0.0 |
0.0 |
Other operating cashflows |
0.0 |
0.0 |
0.0 |
0.0 |
Investing |
(55.3) |
(65.6) |
(136.3) |
(136.2) |
Capex (growth) |
(110.0) |
(140.6) |
(140.6) |
(140.6) |
Proceeds from sale of assets |
0.0 |
0.0 |
0.0 |
0.0 |
Others |
54.7 |
75.0 |
4.3 |
4.4 |
Financing |
(137.4) |
(148.2) |
(155.7) |
(163.4) |
Dividend payments |
(126.4) |
(148.2) |
(155.7) |
(163.4) |
Issue of shares |
0.0 |
0.0 |
0.0 |
0.0 |
Loan repayment |
0.0 |
0.0 |
0.0 |
0.0 |
Others/interest paid |
(11.0) |
0.0 |
0.0 |
0.0 |
Net cash inflow (outflow) |
380.6 |
323.3 |
298.8 |
304.9 |
Beginning cash & cash equivalent |
1,687.9 |
2,073.9 |
2,397.2 |
2,696.0 |
Changes due to forex impact |
5.4 |
0.0 |
0.0 |
0.0 |
Ending cash & cash equivalent |
2,073.9 |
2,397.2 |
2,696.0 |
3,000.9 |
Key Metrics
The following table presents the Key Metrics:
Year to 31 Dec (%) |
2024 |
2025F |
2026F |
2027F |
Profitability |
|
|
|
|
EBITDA margin |
20.4 |
22.0 |
22.1 |
22.1 |
Pre-tax margin |
16.6 |
17.2 |
17.1 |
17.0 |
Net margin |
12.1 |
12.5 |
12.4 |
12.3 |
ROA |
9.4 |
9.0 |
8.7 |
8.4 |
ROE |
10.4 |
10.0 |
9.6 |
9.2 |
Growth |
|
|
|
|
Turnover |
0.7 |
(0.4) |
2.6 |
3.1 |
EBITDA |
18.9 |
7.2 |
3.1 |
3.1 |
Pre-tax profit |
29.1 |
2.8 |
2.3 |
2.3 |
Net profit |
13.8 |
2.8 |
2.3 |
2.3 |
Net profit (adj.) |
13.8 |
2.8 |
2.3 |
2.3 |
EPS |
14.5 |
2.8 |
2.3 |
2.3 |
Leverage |
|
|
|
|
Debt to total capital |
0.0 |
0.0 |
0.0 |
0.0 |
Debt to equity |
0.0 |
0.0 |
0.0 |
0.0 |
Net debt/(cash) to equity |
(49.3) |
(53.3) |
(56.3) |
(59.1) |
Interest cover (x) |
n.a. |
n.a. |
n.a. |
n.a. |